Shivanand Kumatagi Delivers an Interactive Session on ISBT128 Standard
ICCBBA shared on LinkedIn:
”Recently, ICCBBA’s Development Officer for India, Dr Shivanand Kumatagi visited Believers Church Medical College Hospital Tiruvalla, to deliver an interactive session on the ISBT128 Standard.
The session introduced clinicians, transfusion medicine specialists, and laboratory teams to:
• The fundamentals of the ISBT128 Standard
• The mission and global role of ICCBBA
• Key advantages of adopting the ISBT128 Standard for blood and cell therapy services
• Prerequisites and readiness steps for implementing standardized labeling and coding
ICCBBA appreciates the warm welcome and the enthusiastic engagement from the Clinical Hematology and Transfusion Medicine department, as well as all participants who contributed thoughtful questions and valuable discussions.
We look forward to continued collaboration and supporting the institution in its progress toward standardized, globally harmonized labeling for blood and cell therapies.
Mentions:
Chepsy C Philip
Dr Magdelin simon Varghese
Dr Anupa Jacob
Eoin McGrath
Learn more about ICCBBA.”
Stay updated with Hemostasis Today.
-
May 12, 2026, 16:46Tagreed Alkaltham: Why Apheresis Matters in Modern Transfusion Medicine
-
May 12, 2026, 16:37Reinhold Kreutz: Cardiovascular Burden in Acute Intermittent Porphyria Needs Greater Awareness
-
May 12, 2026, 16:33Pablo Corral: The Truth About Very Low LDL-Cholesterol
-
May 12, 2026, 16:24Mildred Lundgren: We Must Talk About the Invisible Causes of Stroke
-
May 12, 2026, 16:17Irene Scala: The Sex Disparities In Access to Acute Stroke Treatments In Italy
-
May 12, 2026, 16:04May Nour: UCLA Health Mobile Stroke Unit Becomes The 1st In The World to Perform mCTA In the Field
-
May 12, 2026, 15:57Leonardo Roever: Prognostic Impact of Lipoprotein(a) and CAR in Elderly Acute Ischemic Stroke Patients
-
May 12, 2026, 15:54Bruno Pougault: Prioritizing Laboratory Tests in Resource-Limited Emergency Care
-
May 12, 2026, 15:37Jennifer Holter Chakrabarty: Supporting the Next Generation of Hematology Researchers